Literature DB >> 8519320

Epidemiology of Salmonella typhimurium: ribosomal DNA analysis of strains from human and animal sources.

A Nastasi1, C Mammina, M R Villafrate.   

Abstract

Salmonella typhimurium is the most frequently identified serovar of Salmonella in Italy. This serovar is characterized by the widespread dissemination among human and non-human sources of phenotypically and genetically well-differentiated clones. In this study 457 strains of S. typhimurium isolated in Italy in the years 1982-91 from human and animal sources were submitted to characterization by the rDNA fingerprinting technique. Application of this typing method, after digestion of chromosomal DNA with HincII endonuclease, confirmed the greatest genetic differentiation of clones of S. typhimurium, allowing reliable identification of 45 rDNA patterns linked into 9 major clusters. rDNA pattern clusters or ribotypes specific to man were not recognized, whereas some rDNA patterns were characteristically related to ducks, pigeons and pet birds. The ribotyping results for isolates from animal hosts suggest that pig and cattle are the main source of human infection.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8519320      PMCID： PMC2272276          DOI： 10.1017/s0950268800050974

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   2.451


  12 in total

1.  A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA.

Authors:  T L Stull; J J LiPuma; T D Edlind
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

2.  Differentiation of staphylococcal species and strains by ribosomal RNA gene restriction patterns.

Authors:  F M Thomson-Carter; P E Carter; T H Pennington
Journal:  J Gen Microbiol       Date:  1989-07

3.  Ribosomal ribonucleic acid gene restriction patterns as potential taxonomic tools.

Authors:  F Grimont; P A Grimont
Journal:  Ann Inst Pasteur Microbiol       Date:  1986 Sep-Oct

4.  Frequency distribution of S. typhi-murium phage types in various countries.

Authors:  W J van Leeuwen; P A Guinée
Journal:  Zentralbl Bakteriol Orig A       Date:  1975

5.  Phage typing of S. typhi murium in the Netherlands. 2. Frequency distributions of S. typhi murium phage types in the Netherlands during 1971 and 1972.

Authors:  W J van Leeuwen; D Pruys; P A Guinée
Journal:  Zentralbl Bakteriol Orig A       Date:  1974-02

6.  Carriage of Yersinia enterocolitica serotype 3 by pigs as a source of human infection.

Authors:  G Wauters
Journal:  Contrib Microbiol Immunol       Date:  1979

7.  Correlation of phaga type, biotype and source in strains of Salmonella typhimurium.

Authors:  E S Anderson; L R Ward; M J De Saxe; D C Old; R Barker; J P Duguid
Journal:  J Hyg (Lond)       Date:  1978-10

8.  Phage type/biotype groups of Salmonella typhimurium in Scotland 1974-6: variation during spread of epidemic clones.

Authors:  R Barker; D C Old; J C Sharp
Journal:  J Hyg (Lond)       Date:  1980-02

9.  rDNA fingerprinting as a tool in epidemiological analysis of Salmonella typhi infections.

Authors:  A Nastasi; C Mammina; M R Villafrate
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

10.  Comparison of plasmid profile analysis, phage typing, and antimicrobial susceptibility testing in characterizing Salmonella typhimurium isolates from outbreaks.

Authors:  S D Holmberg; I K Wachsmuth; F W Hickman-Brenner; M L Cohen
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948
View more
  8 in total

Review 1.  Salmonella enterica serotype Typhimurium and its host-adapted variants.

Authors:  Wolfgang Rabsch; Helene L Andrews; Robert A Kingsley; Rita Prager; Helmut Tschäpe; L Garry Adams; Andreas J Bäumler
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

2.  Host adaptation of pigeon isolates of Salmonella enterica subsp. enterica serovar Typhimurium variant Copenhagen phage type 99 is associated with enhanced macrophage cytotoxicity.

Authors:  Frank Pasmans; Filip Van Immerseel; Marc Heyndrickx; An Martel; Claudine Godard; Christa Wildemauwe; Richard Ducatelle; Freddy Haesebrouck
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  PCR ribotyping for characterizing Salmonella isolates of different serotypes.

Authors:  C Lagatolla; L Dolzani; E Tonin; A Lavenia; M Di Michele; T Tommasini; C Monti-Bragadin
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

4.  Surveillance of multidrug-resistant strains of Salmonella enterica serotype Typhimurium in southern Italy in the years 1992-1997.

Authors:  A Nastasi; C Mammina
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

5.  Multiple genetic typing of Salmonella enterica serotype typhimurium isolates of different phage types (DT104, U302, DT204b, and DT49) from animals and humans in England, Wales, and Northern Ireland.

Authors:  Ernesto Liebana; Lourdes Garcia-Migura; Carol Clouting; Felicity A Clifton-Hadley; Elisabeth Lindsay; E John Threlfall; Stanley W J McDowell; Robert H Davies
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  Endarteritis and mycotic aortic aneurysm caused by an oral strain of Actinobacillus actinomycetemcomitans.

Authors:  M C Martín; M T Andrés; J F Fierro; F J Méndez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

7.  Assessment of virulence of pigeon isolates of Salmonella enterica subsp. enterica serovar typhimurium variant copenhagen for humans.

Authors:  Frank Pasmans; Filip Van Immerseel; Katleen Hermans; Marc Heyndrickx; Jean-Marc Collard; Richard Ducatelle; Freddy Haesebrouck
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

8.  Human Salmonella clinical isolates distinct from those of animal origin.

Authors:  Douglas M Heithoff; William R Shimp; Patrick W Lau; Golnaz Badie; Elena Y Enioutina; Raymond A Daynes; Barbara A Byrne; John K House; Michael J Mahan
Journal:  Appl Environ Microbiol       Date:  2008-02-01       Impact factor: 4.792
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.